UW22123
OPEN TO ACCRUAL
PH1 Study of Intra-anally Administered Lopinavir Ritonavir in Subjects with High-Grade AIN 2,3
UW23016
OPEN TO ACCRUAL
Phase II Liposomal Irinotecan w TAS102 and Bevacizumab for Patients w mCRC
UW23142
OPEN TO ACCRUAL
PII Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for Early Stage Anal Cancer
EA2222
OPEN TO ACCRUAL
Ph III Study of Systemic Tx + or - Hepatic Arterial Infusion for Unresectable Colorectal Liver Mets
NRGGI008
OPEN TO ACCRUAL
II,III Study of Colon Adjuvant Chemo Based on Eval of Residual Disease - CIRCULATE-NORTH AMERICA
UW25102
OPEN TO ACCRUAL
Ph2 Neoadj. Dostarlimab TSR-042 in Stage II and III dMMR Colon Cancer
UW24051
OPEN TO ACCRUAL
Phase 1 and 2 Basket Study of MK-2870 in GI Cancers
UW25112
OPEN TO ACCRUAL
HARMONi-GI3 - P3 Ivonescimab + FOLFOX vs Bevacizumab + FOLFOX for 1st Line mCRC
UWI23-16-01
OPEN TO ACCRUAL
PH2 Study of TPST-1495 in Pts with Familial Adenomatous Polyposis FAP